• Please log in or register to access this feature.

Quality of Care

Physicians' explanations for apparent gaps in the quality of rheumatology care: Results from the US Medicare Physician Quality Reporting System

  1. Jeffrey R. Curtis1,‡,*,
  2. Pradeep Sharma1,
  3. Tarun Arora1,
  4. Aseem Bharat1,
  5. Itara Barnes2,†,
  6. Michael A. Morrisey1,
  7. Meredith Kilgore1,
  8. Kenneth G. Saag1,§,
  9. Nicole C. Wright1,
  10. Huifen G. Yun1,
  11. Elizabeth Delzell1

Article first published online: 30 JAN 2013

DOI: 10.1002/acr.21713

Issue

Arthritis Care & Research

Arthritis Care & Research

Volume 65, Issue 2, pages 235–243, February 2013

Additional Information

How to Cite

Curtis, J. R., Sharma, P., Arora, T., Bharat, A., Barnes, I., Morrisey, M. A., Kilgore, M., Saag, K. G., Wright, N. C., Yun, H. G. and Delzell, E. (2013), Physicians' explanations for apparent gaps in the quality of rheumatology care: Results from the US Medicare Physician Quality Reporting System. Arthritis Care Res, 65: 235–243. doi: 10.1002/acr.21713

Author Information

  1. 1

    University of Alabama at Birmingham

  2. 2

    American College of Rheumatology, Atlanta, Georgia

  1. †

    Medical University of South Carolina, Charleston

  1. ‡

    Dr. Curtis has received consultant fees and/or honoraria (less than $10,000 each) from Abbott, Bristol-Myers Squibb, Crescendo, Lilly, Merck, and Pfizer, and (more than $10,000 each) from Amgen, Centocor, the Consortium of Rheumatology Researchers of North America, Roche/Genentech, and UCB.

  2. §

    Dr. Saag has received consultant fees, speaking fees, and/or honoraria (less than $10,000 each) from Amgen, Lilly, Merck, and Novartis. All co-authors received research support from Amgen.

*510 20th Street South, Faculty Office Towers 802, Birmingham, AL 35294

  1. ‡

    Dr. Curtis has received consultant fees and/or honoraria (less than $10,000 each) from Abbott, Bristol-Myers Squibb, Crescendo, Lilly, Merck, and Pfizer, and (more than $10,000 each) from Amgen, Centocor, the Consortium of Rheumatology Researchers of North America, Roche/Genentech, and UCB.

  2. §

    Dr. Saag has received consultant fees, speaking fees, and/or honoraria (less than $10,000 each) from Amgen, Lilly, Merck, and Novartis. All co-authors received research support from Amgen.

Publication History

  1. Issue published online: 30 JAN 2013
  2. Article first published online: 30 JAN 2013
  3. Accepted manuscript online: 3 MAY 2012 10:25AM EST
  4. Manuscript Accepted: 9 JUL 2012
  5. Manuscript Received: 10 FEB 2012

Funded by

  • Agency for Healthcare Research and Quality. Grant Numbers: R01-HS018517, R01-HS018517, U18-HS016956
  • Amgen
  • NIH. Grant Numbers: AR-053351, AR-052361

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (158K)

Options for accessing this content:

  • If you have access to this content through a society membership, please first log in to your society website.
  • If you would like institutional access to this content, please recommend the title to your librarian.
  • Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
  • You can purchase online access to this Article for a 24-hour period (price varies by title)
    • If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
    • New Users: Please register, then proceed to purchase the article.

If your institution is a registered Wiley Online Library customer, you can log in under your institution's name to see our content. This access is provided by Shibboleth or Athens.

Type your institution's name in the box below. If your institution is a Wiley customer, it will appear in the list of suggested institutions.

Please register to:

  • Save publications, articles and searches
  • Get email alerts
  • Get all the benefits mentioned below!

Register now >

View Full Article with Supporting Information (HTML) Get PDF (158K)